Does adalimumab cause bullous pemphigoid?

Clinical and Experimental Dermatology

Volumn 35, Issue 7, 2010, Pages 795-

  Toosi, S ^a   Bystryn, J C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; DERMATOLOGICAL AGENT; MONOCLONAL ANTIBODY;

BULLOUS PEMPHIGOID; LETTER; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; CHEMICALLY INDUCED; DRUG ERUPTIONS; HUMAN;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; DRUG ERUPTIONS; HUMANS; PEMPHIGOID, BULLOUS; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77956706438     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03813.x     Document Type: Letter

References (3)

1. Stausbøl-Grøn B, Deleuran M, Sommer Hansen E, Kragballe K. Development of bullous pemphigoid during treatment of psoriasis with adalimumab. Clin Exp Dermatol 2009 34: e285 6.
2. Wilczek A, Sticherling M. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship? Int J Dermatol 2006 45: 1353 1357.
3. Yamauchi PS, Lowe NJ, Gindi V. Treatment of coexisting bullous pemphigoid and. Psoriasis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006 54 (Suppl. 2 S121 2. (Pubitemid 43243484)